Epidemiology and Economic Burden of Atopic Dermatitis: Real-World Retrospective Data from a Large Nationwide Israeli Healthcare Provider Database.

ABSTRACT:

Introduction

Real-world data on the epidemiology and economic burden of atopic dermatitis (AD) are limited. Here we describe the epidemiology and economic burden of AD using electronic healthcare data from Israel.

Methods

A retrospective study was performed using the Maccabi Healthcare Services database. AD incidence in 2008-2017 and point prevalence (AD_prev) on 31 December 2017 were described using diagnosis codes for overall patients, and sex and age subgroups. For AD_prev, severity was defined using recently dispensed treatments for AD. Annual healthcare resource utilization in AD prevalent patients was compared with non-AD matched controls using generalized linear modelling. Direct annual costs were estimated also.

Results

AD incidence was 7.0

SUBMITTER: Weil C 

PROVIDER: S-EPMC9329417 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature